Briefing
Performance and Cost-Effectiveness of Tumor Tissue-Modified Viral (TTMV)-Human Papillomavirus (HPV) DNA for Surveillance of HPV-Associated Oropharyngeal Squamous Cell Carcinoma.
A single-institution retrospective analysis assessed surveillance performance and cost of plasma TTMV-HPV DNA, alongside the three-month post-treatment PET scan, in HPV-associated oropharyngeal cancer.
- Design: Evidence level 3
- Assay: NavDx